Galapagos is a pre seed startup based in Japan. 1 investor tracked.
Galapagos is a company founded in 2020 headquartered in Belgium. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Galapagos is a Belgian biotechnology company that discovers and develops small-molecule medicines and conducts clinical trials to treat serious diseases. The company focuses on drug discovery and development across multiple therapeutic areas.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.